Related Experiment Videos
RUNX1/AML1: a central player in hematopoiesis
T Okuda1, M Nishimura, M Nakao
1Departments of Hygiene, Kyoto Prefectural University of Medicine, Japan. okuda@basic.kpu-m.ac.jp
International Journal of Hematology
|November 28, 2001
Summary
Acute myeloid leukemia 1 (AML1) is crucial for developing blood stem cells. This transcription factor guides hematopoietic progenitor cells, essential for forming new blood.
Area of Science:
- Hematology
- Molecular Biology
- Developmental Biology
Background:
- Transcription factors regulate hematopoietic stem cell (HSC) populations.
- Acute myeloid leukemia 1 (AML1), also known as runt-related transcription factor 1 (RUNX1), is a key leukemia-associated transcription factor.
- AML1 was identified at the breakpoint of the t(8;21) translocation and is frequently altered in leukemia.
Purpose of the Study:
- To review the biological properties of AML1 in early hematopoietic development.
- To highlight the essential role of AML1 in the establishment of definitive hematopoiesis.
Main Methods:
- Review of existing literature on AML1 function.
- Analysis of gene-targeting experiments and their implications for hematopoiesis.
Main Results:
- Transcriptionally active AML1 is essential for establishing definitive hematopoiesis.
- AML1 plays a critical role in the emergence of hematopoietic progenitor cells from the hemogenic endothelium in the aorta-gonad-mesonephros region.
- AML1 expression indicates sites of hematopoietic stem cell emergence.
Conclusions:
- AML1 is indispensable for the development of hematopoietic stem cells.
- Understanding AML1's role provides insights into early blood formation and related diseases.